Is tirzepatide good — and what does the evidence actually show?

You've heard tirzepatide works, but what does 'works' actually mean here?

Imagine you've spent a few weeks reading about weight-loss injections. You've seen the headlines. You want to know whether the results are genuine or whether the enthusiasm has outrun the science. That is a reasonable question, and the answer sits in the published data rather than in the hype.

Tirzepatide, sold in the UK as Mounjaro, is a once-weekly injection made by Eli Lilly, and if you are wondering whether tirzepatide is Mounjaro or something different, the short answer is that they are the same medicine under different names. It acts on both the GIP receptor and the GLP-1 receptor, two pathways involved in appetite, blood-sugar regulation and how quickly food moves through your stomach. No other licensed weight-management medicine in the UK works on both simultaneously, which is one reason the results from its trial programme drew attention. In the SURMOUNT-1 study, published in the New England Journal of Medicine, adults without diabetes lost an average of around 20–21% of their starting body weight over 72 weeks at the 15mg dose, figures that were meaningfully higher than anything the GLP-1 class had previously produced in a head-to-head comparison. In SURMOUNT-5, tirzepatide also produced greater average weight reduction than semaglutide 2.4mg in a direct trial involving 751 adults with obesity and no diabetes.

So yes, the evidence base is solid. The question is what it means in practice for someone at your starting point, with your health history.

What tirzepatide is actually like to take, including what arrives at your door

Treatment starts at 2.5mg, a dose designed to let your body adjust rather than produce therapeutic weight loss straight away. A prescriber then steps the dose up, typically every four weeks, through 5, 7.5, 10, 12.5 and 15mg, always at a pace your tolerance guides. The pen itself is a pre-filled KwikPen; one pen contains four weekly doses. You inject once a week into the abdomen, thigh or upper arm, rotating sites.

If you order through a regulated service, what arrives is a tracked DPD parcel in plain, unbranded packaging. The pen goes in the fridge door. That is the practical reality: a weekly injection you do at home, stored between 2°C and 8°C, with the exact storage window spelled out in the Patient Information Leaflet that comes with your prescription.

The NHS medicines page on tirzepatide gives a clear patient-level summary of what to expect, including side effects, storage and what to do if a dose is missed. It is worth reading before you start, and our FAQs cover the practical questions our prescribers hear most often.

How good is tirzepatide for you, specifically, the eligibility picture

The licensed eligibility criteria for private treatment are adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, high cholesterol, prediabetes, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. Passing the number threshold is not the whole story, a prescriber also considers your medical history, current medicines and whether there are any contraindications.

Tirzepatide is not recommended during pregnancy, while breastfeeding, or if you are actively trying to conceive, and it is not licensed for anyone under 18. If you take an oral contraceptive pill, you will need to add a non-oral contraceptive method for the first four weeks of treatment and for four weeks after each dose increase, because absorption of the pill may be reduced, the NHS England guidance on weight-management injections explains this clearly.

NICE recommends tirzepatide on the NHS for adults with a BMI of 35 or above and at least one weight-related comorbidity, within a phased rollout. Private treatment through a regulated pharmacy like nume (like ours) is available without a referral or waiting list, subject to clinical suitability assessed by a GPhC-registered Independent Prescriber.

The side-effect question, and how to weigh it honestly

Deciding how good tirzepatide is for you means factoring in tolerability, not just efficacy numbers. The most common side effects are gastrointestinal: nausea, loose stools, constipation, indigestion, burping and occasionally vomiting. For most people these are most noticeable at the start of treatment or after a dose step-up, and they often ease within days to two weeks. Injecting after a meal rather than before can help. Slow titration (exactly what the licensed schedule is built around) is one of the main tools for managing them.

Less common but serious effects to know about include pancreatitis. Get urgent medical help for severe, persistent stomach pain that may radiate toward the back, especially if accompanied by vomiting. The MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as a known infrequent risk across the GLP-1 class. Gallbladder symptoms, signs of dehydration from prolonged GI illness and allergic reactions also warrant prompt attention.

Most people who complete the trial dosing schedule tolerate tirzepatide well enough to stay on it, but the honest framing is that tolerability varies between individuals, and a prescriber who reviews your consultation can flag any specific reasons for caution. If you want to explore how tirzepatide fits into the broader picture of weight-loss treatment, our weight-loss overview covers the options and how they compare. For a closer look at how good Mounjaro is for weight loss, including what the trial data suggests patients can realistically expect, the results page goes deeper into the trial data. And if cost is part of your thinking, the Mounjaro cost page lays out what private treatment actually involves, there are no hidden fees and no subscription. You can also read more about what tirzepatide is and how it works if you want a fuller grounding before deciding, and our dedicated page on whether Mounjaro is good addresses the question from a clinical and practical angle. Check your eligibility by starting a free consultation with our prescribers whenever you're ready.